RECURRENT BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

Clinical trials for RECURRENT BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new RECURRENT BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM trials appear

Sign up with your email to follow new studies for RECURRENT BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1 Terminated 1

New drug tested for patients with Tough-to-Treat blood cancers

Disease control Completed

This early-stage trial tested the safety and best dose of an investigational drug called flotetuzumab. It involved 13 adults with advanced blood cancers that had returned or stopped responding to standard treatments. The main goal was to understand the drug's side effects and see…

Matched conditions: RECURRENT BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Apr 01, 2026 21:41 UTC

RECURRENT BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

Get alerted when new RECURRENT BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM trials appear

New drug tested for patients with Tough-to-Treat blood cancers